Topical Ruxolitinib Evaluation in Chronic Hand Eczema
NCT05906628
Dermatitis, Eczema
Phoenix, Arizona, United States
View Trial DetailsNCT Number: NCT05471934
The participants presenting with hand problems and meeting the inclusion criteria are asked to apply the study product for one month. They are evaluated before and after treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Dermatology practices, Roma, Italy
The international, open, observational survey is conducted in 3 different countries.
Regarding the statistical analysis, the global satisfaction is described in 5 classes and in 2 classes "Satisfied + Very satisfied" vs. "Neither satisfied nor dissatisfied + Not so satisfied + Not at all satisfied". The 95% Confidence Interval (CI) of the percent of "Satisfied + Very satisfied" is also given.
On patients who already used cream at the inclusion, the following analyses are performed:
For the analysis of the hands problems, each sign is described at the inclusion and at the evaluation visit. The difference Evaluation-Inclusion is also given. The evolution of the sign is performed by a Wilcoxon test for matched samples.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from baseline to Day28
satisfaction questionnaire with a 5-point scale
Time frame: from baseline to Day28
evaluation on a 10-point scale (0 Not at all to 10 Very strong)
Cosmetique Active International
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05906628
Dermatitis, Eczema
Phoenix, Arizona, United States
View Trial DetailsNCT00404196
Hand Eczema
Nottingham, United Kingdom
View Trial DetailsNCT00488241
Dermatitis, Eczema
Berlin, Germany
View Trial DetailsNCT05763914
Hand Eczema
Køge, Region Sjælland, Denmark
View Trial Details